Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination.
about
Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalitiesAntigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune SeraInduction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humansMatrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets.Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines.Workshop report: Immunoassay standardisation for "universal" influenza vaccines.Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability.Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.Viral Persistence Induces Antibody Inflation without Altering Antibody AvidityInter-Clade Protection Offered by Mw-Adjuvanted Recombinant HA, NP Proteins, and M2e Peptide Combination Vaccine in Mice Correlates with Cellular Immune Response.Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™.Dissecting the hemagglutinin head and stalk-specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination.
P2860
Q26796420-1968D1F3-D352-4879-B930-AF600E6AF782Q27468808-092B177E-4750-485E-9DE8-9B0BCE865560Q30207889-B175C0D5-FCDF-4846-AF61-8043B4F53B5DQ30376350-5EE06781-98F3-4243-B88E-CF89313669E0Q30400179-E86D53F4-C9B7-42B2-A78E-C99DAA74C5DFQ30401247-C51F4E5E-2246-4AF1-9B49-0A16FDD8F23CQ33619871-08CC917C-C894-4406-8E2C-E08CEFCC3402Q36009558-C548AA4E-E4EB-4F46-842E-537B199A586EQ36496580-FF7CC332-996B-42F4-B3E0-BEE93DC69543Q36811912-880E7D5F-3BD4-4CDB-8260-700611EACB8FQ37570525-5DE1514E-F593-4C51-9513-2536EE69175AQ41118592-53CF2A08-2658-4985-9EFD-177392F0AEECQ47136777-4BD6E3F9-A46C-4AE9-95A0-0A47036FCE2E
P2860
Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Serum IgG titres, but not avid ...... sponse after H5N1 vaccination.
@ast
Serum IgG titres, but not avid ...... sponse after H5N1 vaccination.
@en
type
label
Serum IgG titres, but not avid ...... sponse after H5N1 vaccination.
@ast
Serum IgG titres, but not avid ...... sponse after H5N1 vaccination.
@en
prefLabel
Serum IgG titres, but not avid ...... sponse after H5N1 vaccination.
@ast
Serum IgG titres, but not avid ...... sponse after H5N1 vaccination.
@en
P2093
P50
P1433
P1476
Serum IgG titres, but not avid ...... esponse after H5N1 vaccination
@en
P2093
Aram Afsar
Arnt Johan Raae
Gabriel Kristian Pedersen
Geir Bredholt
Haakon Sjursen
Jane Kristin Nøstbakken
Katja Höschler
Lucy Breakwell
Maria Zambon
Rishi Delan Pathirana
P304
P356
10.1016/J.VACCINE.2014.06.009
P407
P577
2014-06-18T00:00:00Z